Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Brand

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Plos One|October 12, 2013
Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized dataRonald Brand, Hein Putter, Anja van Biezen, et al.
Anesthesiology|January 18, 2014
Patient blood management in elective total hip- and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dlCynthia So-Osman, Rob G H H Nelissen, Ankie W M M Koopman-van Gemert, et al.
Ebiomedicine|February 5, 2016
Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort StudyAlois Gratwohl, Anna Sureda, Helen Baldomero, et al.
Anesthesiology|January 16, 2014
Patient blood management in elective total hip- and knee-replacement surgery (Part 1): a randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patientsCynthia So-Osman, Rob G H H Nelissen, Ankie W M M Koopman-van Gemert, et al.
Haematologica|August 3, 2014
Impact of the International Prognostic Scoring System cytogenetic risk groups on the outcome of patients with primary myelodysplastic syndromes undergoing allogeneic stem cell transplantation from human leukocyte antigen-identical siblings: a retrospective analysis of the European Society for Blood and Marrow Transplantation-Chronic Malignancies Working PartyFrancesco Onida, Ronald Brand, Anja van Biezen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemiaZiyi Lim, Ronald Brand, Rodrigo Martino, et al.
Annals of Surgery|June 28, 2012
Successful and safe introduction of laparoscopic colorectal cancer surgery in Dutch hospitalsNikki E Kolfschoten, Nicoline J van Leersum, Gea A Gooiker, et al.
Haematologica|March 23, 2010
Impact of genomic risk factors on outcome after hematopoietic stem cell transplantation for patients with chronic myeloid leukemiaAnne M Dickinson, Kim F Pearce, Jean Norden, et al.
Blood|April 7, 2006
Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromesRodrigo Martino, Simona Iacobelli, Ronald Brand, et al.
Transfusion|June 27, 2014
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxideCurly Morris, Liesbeth de Wreede, Marijke Scholten, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Plos One|October 12, 2013
Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized dataRonald Brand, Hein Putter, Anja van Biezen, et al.
Anesthesiology|January 18, 2014
Patient blood management in elective total hip- and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dlCynthia So-Osman, Rob G H H Nelissen, Ankie W M M Koopman-van Gemert, et al.
Ebiomedicine|February 5, 2016
Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort StudyAlois Gratwohl, Anna Sureda, Helen Baldomero, et al.
Anesthesiology|January 16, 2014
Patient blood management in elective total hip- and knee-replacement surgery (Part 1): a randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patientsCynthia So-Osman, Rob G H H Nelissen, Ankie W M M Koopman-van Gemert, et al.
Haematologica|August 3, 2014
Impact of the International Prognostic Scoring System cytogenetic risk groups on the outcome of patients with primary myelodysplastic syndromes undergoing allogeneic stem cell transplantation from human leukocyte antigen-identical siblings: a retrospective analysis of the European Society for Blood and Marrow Transplantation-Chronic Malignancies Working PartyFrancesco Onida, Ronald Brand, Anja van Biezen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemiaZiyi Lim, Ronald Brand, Rodrigo Martino, et al.
Annals of Surgery|June 28, 2012
Successful and safe introduction of laparoscopic colorectal cancer surgery in Dutch hospitalsNikki E Kolfschoten, Nicoline J van Leersum, Gea A Gooiker, et al.
Haematologica|March 23, 2010
Impact of genomic risk factors on outcome after hematopoietic stem cell transplantation for patients with chronic myeloid leukemiaAnne M Dickinson, Kim F Pearce, Jean Norden, et al.
Blood|April 7, 2006
Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromesRodrigo Martino, Simona Iacobelli, Ronald Brand, et al.
Transfusion|June 27, 2014
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxideCurly Morris, Liesbeth de Wreede, Marijke Scholten, et al.
Pageof 11